B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

AURKB

MOLECULAR TARGET

aurora kinase B

UniProt: Q96GD4NCBI Gene: 921218 compounds

AURKB (aurora kinase B) is targeted by 18 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting AURKB

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1Sorafenib1.956
2sp6001251.393
3fisetin1.102
4Quercetin1.102
5Axitinib1.102
6Crizotinib1.102
7kenpaullone1.102
81-(5,8-dihydro-1,4-dihydroxy-5,8-dioxo-2-naphthyl)-4-methylpent-3-en-1-yl cinnamate [Supplementary Concept]1.102
9Apigenin 5,7,4'-trihydroxy-flavone,0.691
10Kaempferols0.691
11Luteolin 5,7,3',4'-tetrahydroxy-flavone,0.691
12myricetin-3-O-galactopyranoside [Supplementary Concept]0.691
13Dasatinib0.691
14hydroxyfasudil [Supplementary Concept]0.691
15isorhamnetin-3-O-beta-D-glucopyranosyl-(1-3)-alpha-L-rhamnopyranosyl-(1-6)-beta-D-galactopyranoside [Supplementary Concept] from0.691
16juglone hydroxylase [Supplementary Concept] catalyzes0.691
17scutellarein0.691
18tamarixetin0.691

About AURKB as a Drug Target

AURKB (aurora kinase B) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 18 compounds with documented AURKB interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

AURKB inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.